Literature DB >> 12812012

Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III).

Ryne Paulose-Ram1, Rosemarie Hirsch, Charles Dillon, Katalin Losonczy, Michael Cooper, Yechiam Ostchega.   

Abstract

PURPOSE: To estimate prescription and non-prescription analgesic use in a nationally representative sample of US adults.
METHODS: Data collected during the third National Health and Nutrition Examination Survey (1988-1994), for persons 17 years and older were analyzed (n = 20,050). During the household interview, respondents reported use, in the last month, of prescription and non-prescription analgesics.
RESULTS: An estimated 147 million adults reported monthly analgesic use, Prescription analgesic use was 9% while non-prescription use was 76%. Females were more likely than males to use prescription (11 vs. 7%, p < 0.001) and non-prescription (81 vs. 71%, p < 0.001) analgesics. Across race-ethnicity groups, males (approximately 8%) and females (11-13%) had similar age-adjusted prescription analgesic use. Non-prescription analgesic use was higher among non-Hispanic whites than non-Hispanic blacks and Mexican-Americans for males (76 vs. 53% (p < 0.001) and 59% (p < 0.001), respectively) and females (85 vs. 68% (p < 0.001) and 71% (p < 0.001), respectively). With increasing age, prescription analgesic use increased whereas non-prescription use decreased. Approximately 30% of adults used multiple analgesics during a 1-month period. This was more common among females (35%) than males (25%, p < 0.001) and among younger (17-44 years, 33%) rather than older age groups (45+ years, 26%, p < 0.001).
CONCLUSIONS: Analgesic use among US adults is extremely high, specifically of non-prescription analgesics. Given this, health care providers and consumers should be aware of potential adverse effects and monitor use closely.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812012     DOI: 10.1002/pds.755

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  52 in total

1.  Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.

Authors:  M Cary Reid; David A Bennett; Wen G Chen; Basil A Eldadah; John T Farrar; Bruce Ferrell; Rollin M Gallagher; Joseph T Hanlon; Keela Herr; Susan D Horn; Charles E Inturrisi; Salma Lemtouni; Yu Woody Lin; Kaleb Michaud; R Sean Morrison; Tuhina Neogi; Linda L Porter; Daniel H Solomon; Michael Von Korff; Karen Weiss; James Witter; Kevin L Zacharoff
Journal:  Pain Med       Date:  2011-08-11       Impact factor: 3.750

2.  Analgesic-Related Medication Errors Reported to US Poison Control Centers.

Authors:  Madhulika Eluri; Henry A Spiller; Marcel J Casavant; Thitphalak Chounthirath; Kristen A Conner; Gary A Smith
Journal:  Pain Med       Date:  2018-12-01       Impact factor: 3.750

3.  Predictors of Improvements in Pain Intensity in a National Cohort of Older Veterans With Chronic Pain.

Authors:  Steven K Dobscha; Travis I Lovejoy; Benjamin J Morasco; Anne E Kovas; Dawn M Peters; Kyle Hart; J Lucas Williams; Bentson H McFarland
Journal:  J Pain       Date:  2016-04-04       Impact factor: 5.820

4.  Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice.

Authors:  Sally Hull; Rohini Mathur; Gavin Dreyer; Muhammad Magdi Yaqoob
Journal:  Br J Gen Pract       Date:  2014-07       Impact factor: 5.386

Review 5.  Common medications and prostate cancer mortality: a review.

Authors:  Konrad H Stopsack; Alexandra J Greenberg; Lorelei A Mucci
Journal:  World J Urol       Date:  2016-08-04       Impact factor: 4.226

6.  Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009-2010.

Authors:  Gregory Castelli; Ashley Petrone; Jun Xiang; Carl Shrader; Dana King
Journal:  Am J Cardiovasc Drugs       Date:  2017-06       Impact factor: 3.571

7.  A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain.

Authors:  Todd Berner; Heather Thomson; Ann Hartry; R Amy Puenpatom; Rami Ben-Joseph; Sheryl L Szeinbach
Journal:  P T       Date:  2011-03

8.  Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden.

Authors:  David C Montrose; Xi Kathy Zhou; Erin M McNally; Erika Sue; Rhonda K Yantiss; Steven S Gross; Nitai D Leve; Edward D Karoly; Chen S Suen; Lilan Ling; Robert Benezra; Eric G Pamer; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2016-07-18

9.  Patterns and predictors of persistent opioid use following hip or knee arthroplasty.

Authors:  S C Kim; N Choudhry; J M Franklin; K Bykov; M Eikermann; J Lii; M A Fischer; B T Bateman
Journal:  Osteoarthritis Cartilage       Date:  2017-04-19       Impact factor: 6.576

10.  Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study.

Authors:  Sven Schmiedl; Marietta Rottenkolber; Joerg Hasford; Dominik Rottenkolber; Katrin Farker; Bernd Drewelow; Marion Hippius; Karen Saljé; Petra Thürmann
Journal:  Drug Saf       Date:  2014-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.